Sigachi Industries Limited (BOM:543389)
29.38
-0.38 (-1.28%)
At close: Oct 7, 2026
Sigachi Industries Revenue
Sigachi Industries had revenue of 1.21B INR in the quarter ending June 30, 2026, a decrease of -5.44%. This brings the company's revenue in the last twelve months to 4.71B, down -9.58% year-over-year. In the fiscal year ending March 31, 2026, Sigachi Industries had annual revenue of 4.78B, down -4.50%.
Revenue (ttm)
4.71B
Revenue Growth
-9.58%
P/S Ratio
2.43
Revenue / Employee
3.36M
Employees
1,400
Market Cap
11.28B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.78B | -224.98M | -4.50% |
| Mar 31, 2025 | 5.00B | 962.25M | 23.81% |
| Mar 31, 2024 | 4.04B | 1.02B | 33.79% |
| Mar 31, 2023 | 3.02B | 517.55M | 20.68% |
| Mar 31, 2022 | 2.50B | 544.85M | 27.83% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 25.24B |
| Symbiotec Pharmalab | 8.84B |
| Bajaj HealthCare | 6.28B |
| NGL Fine-Chem | 5.36B |
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Gujarat Themis Biosyn | 1.74B |
| Influx Healthtech | 1.47B |
| Smruthi Organics | 1.12B |